Breaking News

Aptar CSP Increases Capacity for Active Packaging Solutions

3-Phase Activ-Polymer platform technology protects electrochemical, lateral flow, and molecular diagnostic test kits.

By: Contract Pharma

Contract Pharma Staff

Aptar CSP Technologies, an active packaging solutions provider, has expanded capacity for producing multiple configurations of its 3-Phase Activ-Polymer technology to support increased demand for diagnostic test kits protection solutions.   The recent surge in the development of new COVID-19 test kits in tandem with pandemic-related supply chain challenges has led to increased demand for solutions to improve result accuracy of critical diagnostic tests. Aptar’s 3-Phase Activ-Polymer technology...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters